Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

AD/PD 2022 | Diagnostic tools for neurodegenerative disease

Davide Tampellini, PhD, U1195 INSERM Institute Baulieu, Paris, France, speaks on the importance of diagnostic tools for neurodegenerative disease, particularly the development of cerebrospinal fluid, blood, and MRI biomarkers. Discriminating between different types of dementia, such as Alzheimer’s disease, frontotemporal dementia, and Lewy body dementia, is important to monitor patients and their treatment. This interview took place at the AD/PD™ 2022 Conference in Barcelona, Spain.